Aclaris Total Cash From Operating Activities vs Gross Profit Margin Analysis

ACRS Stock  USD 3.55  0.08  2.20%   
Aclaris Therapeutics financial indicator trend analysis is way more than just evaluating Aclaris Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Aclaris Therapeutics is a good investment. Please check the relationship between Aclaris Therapeutics Total Cash From Operating Activities and its Gross Profit Margin accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aclaris Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Aclaris Stock please use our How to Invest in Aclaris Therapeutics guide.

Total Cash From Operating Activities vs Gross Profit Margin

Total Cash From Operating Activities vs Gross Profit Margin Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Aclaris Therapeutics Total Cash From Operating Activities account and Gross Profit Margin. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Aclaris Therapeutics' Total Cash From Operating Activities and Gross Profit Margin is -0.02. Overlapping area represents the amount of variation of Total Cash From Operating Activities that can explain the historical movement of Gross Profit Margin in the same time period over historical financial statements of Aclaris Therapeutics, assuming nothing else is changed. The correlation between historical values of Aclaris Therapeutics' Total Cash From Operating Activities and Gross Profit Margin is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Cash From Operating Activities of Aclaris Therapeutics are associated (or correlated) with its Gross Profit Margin. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Gross Profit Margin has no effect on the direction of Total Cash From Operating Activities i.e., Aclaris Therapeutics' Total Cash From Operating Activities and Gross Profit Margin go up and down completely randomly.

Correlation Coefficient

-0.02
Relationship DirectionNegative 
Relationship StrengthInsignificant

Total Cash From Operating Activities

Gross Profit Margin

Most indicators from Aclaris Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Aclaris Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aclaris Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Aclaris Stock please use our How to Invest in Aclaris Therapeutics guide.Discontinued Operations is likely to gain to about 167.8 K in 2024, whereas Selling General Administrative is likely to drop slightly above 21.3 M in 2024.

Aclaris Therapeutics fundamental ratios Correlations

0.770.790.990.580.68-0.48-0.620.860.540.740.960.70.94-0.040.710.790.510.780.970.280.97-0.10.440.590.49
0.770.730.70.350.69-0.22-0.560.820.30.550.730.660.70.340.730.720.70.60.730.320.630.130.60.720.04
0.790.730.720.670.79-0.24-0.860.940.310.80.660.910.610.030.680.930.690.890.690.570.770.270.380.930.46
0.990.70.720.520.64-0.53-0.560.790.580.680.970.640.95-0.170.650.740.360.710.980.260.98-0.190.390.510.5
0.580.350.670.520.22-0.11-0.90.530.120.610.550.820.540.040.720.80.550.90.550.080.620.240.290.510.79
0.680.690.790.640.22-0.37-0.490.890.50.790.510.50.480.020.330.580.550.610.560.660.590.250.230.810.11
-0.48-0.22-0.24-0.53-0.11-0.370.13-0.34-0.99-0.23-0.51-0.21-0.580.32-0.16-0.260.07-0.21-0.52-0.26-0.48-0.060.07-0.05-0.14
-0.62-0.56-0.86-0.56-0.9-0.490.13-0.73-0.17-0.65-0.56-0.94-0.520.01-0.71-0.93-0.62-0.92-0.57-0.42-0.63-0.31-0.29-0.8-0.64
0.860.820.940.790.530.89-0.34-0.730.430.810.740.780.70.120.650.840.720.830.770.610.770.250.410.90.3
0.540.30.310.580.120.5-0.99-0.170.430.340.540.240.6-0.280.170.30.010.270.550.290.520.09-0.050.140.13
0.740.550.80.680.610.79-0.23-0.650.810.340.560.60.530.070.510.650.640.850.590.280.70.260.350.690.55
0.960.730.660.970.550.51-0.51-0.560.740.540.560.640.99-0.080.730.740.390.691.00.210.93-0.210.460.450.48
0.70.660.910.640.820.5-0.21-0.940.780.240.60.640.610.070.770.980.660.870.660.390.710.250.350.80.54
0.940.70.610.950.540.48-0.58-0.520.70.60.530.990.61-0.080.730.70.350.660.980.180.91-0.140.440.380.44
-0.040.340.03-0.170.040.020.320.010.12-0.280.07-0.080.07-0.080.260.00.720.08-0.1-0.27-0.220.40.360.12-0.38
0.710.730.680.650.720.33-0.16-0.710.650.170.510.730.770.730.260.790.640.730.70.150.660.240.820.550.45
0.790.720.930.740.80.58-0.26-0.930.840.30.650.740.980.70.00.790.630.890.750.420.80.20.390.820.54
0.510.70.690.360.550.550.07-0.620.720.010.640.390.660.350.720.640.630.710.390.190.360.490.490.710.12
0.780.60.890.710.90.61-0.21-0.920.830.270.850.690.870.660.080.730.890.710.70.350.760.290.360.770.67
0.970.730.690.980.550.56-0.52-0.570.770.550.591.00.660.98-0.10.70.750.390.70.250.95-0.210.410.480.48
0.280.320.570.260.080.66-0.26-0.420.610.290.280.210.390.18-0.270.150.420.190.350.250.240.280.040.7-0.01
0.970.630.770.980.620.59-0.48-0.630.770.520.70.930.710.91-0.220.660.80.360.760.950.24-0.190.350.530.62
-0.10.130.27-0.190.240.25-0.06-0.310.250.090.26-0.210.25-0.140.40.240.20.490.29-0.210.28-0.190.170.39-0.2
0.440.60.380.390.290.230.07-0.290.41-0.050.350.460.350.440.360.820.390.490.360.410.040.350.170.340.17
0.590.720.930.510.510.81-0.05-0.80.90.140.690.450.80.380.120.550.820.710.770.480.70.530.390.340.22
0.490.040.460.50.790.11-0.14-0.640.30.130.550.480.540.44-0.380.450.540.120.670.48-0.010.62-0.20.170.22
Click cells to compare fundamentals

Aclaris Therapeutics Account Relationship Matchups

Aclaris Therapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets98.3M70.8M251.2M254.6M197.4M169.3M
Other Current Liab4.2M8.4M11.6M10.2M2.2M2.1M
Total Current Liabilities22.4M14.9M22.9M21.9M31.0M16.3M
Total Stockholder Equity69.9M37.7M197.3M197.6M157.2M133.2M
Other Liab2.4M7.6M28.8M33.5M38.5M40.4M
Property Plant And Equipment Net2.5M1.7M1.3M1.1M1.6M1.6M
Net Debt(35.3M)(42.9M)(26.7M)(44.6M)(39.5M)(41.4M)
Retained Earnings(453.5M)(504.5M)(595.4M)(682.3M)(770.8M)(732.3M)
Accounts Payable9.9M5.3M10.0M10.4M8.9M7.2M
Cash35.9M54.1M27.3M45.3M39.9M52.9M
Non Current Assets Total14.5M13.3M46.2M23.0M68.5M72.0M
Cash And Short Term Investments75.0M54.1M225.7M229.8M119.1M137.6M
Common Stock Shares Outstanding41.3M42.5M56.7M65.2M69.8M38.5M
Short Term Investments39.1M32.1M164.1M172.3M79.2M96.3M
Liabilities And Stockholders Equity98.3M70.8M251.2M254.6M197.4M169.3M
Non Current Liabilities Total6.0M18.3M30.9M35.0M9.3M8.8M
Other Current Assets3.1M5.2M26.0M13.5M9.5M7.2M
Other Stockholder Equity523.5M542.3M793.0M880.8M928.1M495.6M
Total Liab28.4M33.1M53.9M57.0M40.2M36.1M
Property Plant And Equipment Gross2.5M1.7M4.7M5.1M5.8M6.1M
Total Current Assets83.8M57.5M205.0M231.6M128.9M139.1M
Accumulated Other Comprehensive Income(66K)(94K)(224K)(897K)(106K)(111.3K)
Property Plant Equipment7.2M1.7M1.3M1.1M1.3M1.9M
Net Tangible Assets62.7M30.5M190.3M190.6M219.2M135.0M
Non Currrent Assets Other4.8M4.5M3.6M(630K)1.7M1.8M
Other Assets92K4.5M251.2M1.7M2.0M1.9M
Net Receivables704K772K623K484K298K283.1K
Retained Earnings Total Equity(453.5M)(504.5M)(595.4M)(682.3M)(614.1M)(583.4M)
Capital Surpluse523.5M542.3M793.0M880.8M1.0B553.9M
Inventory791K5.0M(34.2M)(12.2M)(11.0M)(10.5M)
Intangible Assets7.2M7.1M7.0M7.0M269K255.6K
Non Current Liabilities Other5.4M7.2M30.6M34.7M9.3M13.1M
Short Long Term Debt Total658K11.3M693K684K426K404.7K
Capital Lease Obligations637K603K693K684K426K594.9K
Net Invested Capital69.9M48.3M197.3M197.6M157.2M130.4M
Net Working Capital61.4M42.6M182.1M209.6M97.9M106.7M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Aclaris Stock Analysis

When running Aclaris Therapeutics' price analysis, check to measure Aclaris Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aclaris Therapeutics is operating at the current time. Most of Aclaris Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aclaris Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aclaris Therapeutics' price. Additionally, you may evaluate how the addition of Aclaris Therapeutics to your portfolios can decrease your overall portfolio volatility.